Necroptosis Inhibition Preserves Diaphragm Function in Experimental Sepsis
The American Journal of Pathology · 2025
DOI: 10.1016/j.ajpath.2025.08.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2025. Verfasst von Xin Fu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Therapy, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Diaphragm, Sepsis, Necroptosis, Imidazoles. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Sichuan Province.
Themen: Sepsis
Abstract (Originalsprache)
Diaphragm dysfunction in sepsis remains a critical challenge in intensive care, yet its underlying mechanisms are poorly understood. This study investigates the role of necroptosis, a recently recognized form of programmed cell death, in sepsis-induced diaphragm dysfunction. A cecal ligation and puncture model in C57BL/6 mice was employed to induce sepsis. Diaphragm function was assessed through ultrasound imaging and pulmonary function testing. Necroptosis markers [receptor-interacting protein kinase (Ripk)-1, Ripk3, and mixed-lineage kinase domain-like protein (Mlkl)] and inflammatory cytokines [Il-6, tumor necrosis factor (Tnf)-α] were quantified using real-time quantitative RT-PCR, Western blot analysis, and enzyme-linked immunosorbent assay. The effect of the necroptosis inhibitor necrostatin-1 (Nec-1) was evaluated in vivo and in vitro. Septic mice exhibited significant diaphragm dysfunction correlated with an elevated expression of necroptosis markers and inflammatory cytokines in diaphragm tissue. Nec-1 treatment not only suppressed necroptosis but also markedly improved diaphragm function and respiratory parameters. In vitro, peritoneal lavage fluid from septic mice induced necroptosis in C2C12 myotubes, an effect mitigated by Nec-1. The findings unveil necroptosis as a key player in sepsis-induced diaphragm dysfunction. A novel mechanism is proposed in which Tnf-α, produced by activated peritoneal macrophages, triggers diaphragm necroptosis. This study not only advances the understanding of the pathophysiology of sepsis but also identifies necroptosis inhibition as a promising therapeutic strategy for preserving diaphragm function in sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Therapy, West China Hospital, Sichuan University, Chengdu, China.
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
- Department of Critical Care Medicine, Ziyang Central Hospital, Ziyang, China.
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China. Electronic address: yjingscu@163.com.
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China. Electronic address: qinwu@wchscu.edu.cn.
Förderung
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Fu, X., Wang, L. T., Xu, Q., Yao, H., Xia, X. X., Wang, Y., Li, T. L., Yao, Z. W., Luo, J., Liang, G. P., Yang, J., & Wu, Q. (2025). Necroptosis Inhibition Preserves Diaphragm Function in Experimental Sepsis. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2025.08.013
Vancouver
Fu X, Wang LT, Xu Q, Yao H, Xia XX, Wang Y, et al. Necroptosis Inhibition Preserves Diaphragm Function in Experimental Sepsis. The American Journal of Pathology. 2025. doi:10.1016/j.ajpath.2025.08.013
BibTeX
@article{Fu2025,
author = {Fu, Xin and Wang, Lie-Tao and Xu, Qian and Yao, Hua and Xia, Xiao-Xiao and Wang, Yucong and Li, Tong-Ling and Yao, Zhi-Wei and Luo, Ji and Liang, Guo-Peng and Yang, Jing and Wu, Qin},
title = {Necroptosis Inhibition Preserves Diaphragm Function in Experimental Sepsis},
journal = {The American Journal of Pathology},
year = {2025},
doi = {10.1016/j.ajpath.2025.08.013}
}
EUVIMED